Trial Profile
A study evaluating the effect of chronic kidney disease on platelet function in acute coronary syndrome patients, treated with dual antiplatelet therapy (DAPT)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary) ; Aspirin
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 27 Feb 2016 New trial record